Skip to main content
. Author manuscript; available in PMC: 2021 Nov 30.
Published in final edited form as: Psychiatry Res Neuroimaging. 2020 Sep 2;305:111174. doi: 10.1016/j.pscychresns.2020.111174

Table 3.

Number and percentages of subtypes for cases and controls for all subtypes.

Cocaine Use (n = 84) No Cocaine Use (n = 24) Independent Control Group (n = 52) All Controls b (n = 76)
Pattern Type Documented Subtypes Subtypes Identified (%) Subtypes Identified (%) Subtypes Identified (%) Subtypes Identified (%)
Type I 14 13 (92.9) 6 (42.9) 9 (64.3) 10 (71.4)
Type II 9 6 (66.7) 3 (33.3) 6 (66.7) 6 (66.7)
Type III 16 13 (81.3) 6 (37.5) 6 (37.5) 8 (50.0)
Type IV 5 3 (60) 3(60) 2 (40) 3 (60)
Total a 44 35 (79.5) 18 (40.9) 23 (52.3) 27 (61.4)
a

This considers the number of subtypes identified within cases and controls respectively, over the total number of previously documented subtypes. Note that the denominator is includes documented subtypes identified within this sample.

b

Includes all subtypes identified between both sets of control groups.